Compare CAC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAC | ETON |
|---|---|---|
| Founded | 1875 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 876.2M | 872.7M |
| IPO Year | 1996 | 2018 |
| Metric | CAC | ETON |
|---|---|---|
| Price | $53.97 | $36.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $47.00 | $39.33 |
| AVG Volume (30 Days) | 101.7K | ★ 384.8K |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 6.08 | N/A |
| EPS | ★ 1.29 | 0.05 |
| Revenue | $41,739,000.00 | ★ $79,950,000.00 |
| Revenue This Year | $19.15 | $40.90 |
| Revenue Next Year | $6.05 | $47.23 |
| P/E Ratio | ★ $41.83 | $734.60 |
| Revenue Growth | 16.96 | ★ 104.94 |
| 52 Week Low | $35.00 | $13.76 |
| 52 Week High | $54.79 | $36.95 |
| Indicator | CAC | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 66.69 | 72.74 |
| Support Level | $46.61 | $15.77 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.53 | 1.70 |
| MACD | 0.19 | 0.42 |
| Stochastic Oscillator | 85.06 | 89.10 |
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.